ResearchMoz

United States Cardiovascular Surgery Market Outlook to 2020

GlobalData
Published Date » 2014-05-09
No. Of Pages » 144
   
 "United States Cardiovascular Surgery Market Outlook to 2020", provides key market data on the United States Cardiovascular Surgery Market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Beating Heart Surgery Systems, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment and Perfusion Disposables. 
   
 The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Surgery Market wherever available. 
   
 The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital...

Table of content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 9
2.1 What Is This Report About? 9
2.2 Cardiovascular Surgery Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10

3 Cardiovascular Surgery Market, United States 12
3.1 Cardiovascular Surgery Market, United States, Revenue ($m), 2005-2012 12
3.2 Cardiovascular Surgery Market, United States, Revenue ($m), 2012-2020 14
3.2.1 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2005-2012 16
3.2.2 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2005-2012 18
3.2.3 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2012-2020 20
3.2.4 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2012-2020 22
3.3 Cardiovascular Surgery Market, United States, Volume (Units), 2005-2012 24
3.4 Cardiovascular Surgery Market, United States, Volume (Units), 2012-2020 26
3.4.1 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2005-2012 28
3.4.2 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2005-2012 30
3.4.3 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2012-2020 32
3.4.4 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2012-2020 34
3.5 Cardiovascular Surgery Market, United States, Average Price ($), 2005-2020 36
3.6 Cardiovascular Surgery Market, United States, Distribution Share by Revenue ($m), 2011-2012 38
3.7 Cardiovascular Surgery Market, United States, Company Share by Revenue ($m), 2011-2012 39

4 Overview of Key Companies in United States, Cardiovascular Surgery Market 41
4.1 Medtronic, Inc. 41
4.1.1 Company Overview 41
4.2 Maquet Holding B.V. & Co. KG. 41
4.2.1 Company Overview 41
4.3 Sorin S.p.A. 41
4.3.1 Company Overview 41
4.4 Terumo Corporation 42
4.4.1 Company Overview 42

5 Cardiovascular Surgery Market Pipeline Products 43

6 Financial Deals Landscape 44
6.1 Acquisition 44
6.1.1 Sorin Acquires California Medical Labs, Maker Of Cardiovascular Cannulae, For US$14 Million 44
6.2 Debt Offerings 46
6.2.1 Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 46
6.2.2 Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 48
6.2.3 Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 50
6.2.4 Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 52
6.2.5 Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 54
6.2.6 Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 56
6.2.7 Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 58
6.3 Equity Offerings 60
6.3.1 Cardica Prices Public Offering Of Preferred Stock For US$16.3 Million 60
6.3.2 Cardica Completes Public Offering Of Shares For US$31.8 Million 62
6.3.3 Cardica Completes Public Offering Of Shares For US$15 Million 64
6.4 Partnerships 65
6.4.1 Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse 65
6.4.2 Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 66
6.4.3 Minnetronix Enters Into Licensing Agreement With Penn State Research Foundation For Wireless Energy Transmission Technology 67
6.5 Venture Financing 68
6.5.1 Tenaxis Medical Raises US$1.4 Million In Venture Financing 68
6.5.2 Medrobotics Raises US$21.3 Million In Venture Financing 69
6.5.3 BioVentrix Raises US$0.5 Million In Venture Financing 70
6.5.4 CHF Technologies Raises US$0.8 Million In Venture Financing 71

7 Recent Developments 72
7.1 Corporate Communications 72
7.1.1 Feb 18, 2014: SurModics Announces Changes to Board of Directors 72
7.1.2 Jan 13, 2014: Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing 73
7.1.3 Dec 04, 2013: Cook Medical Names Rob Lyles Executive Vice President 73
7.1.4 Dec 04, 2013: Mark Breedlove Named Vice President of Cook Medical’s Peripheral Intervention Clinical Division 73
7.1.5 Oct 01, 2013: Gretchen Gutman Named Vice President of Public Policy for Cook Group 74
7.1.6 Sep 23, 2013: BioVentrix Appoints Cardiology Expert Dr. Serjan Nikolic as Vice President of Therapy Development 74
7.1.7 Sep 20, 2013: SurModics Announces Board Changes 75
7.1.8 Aug 22, 2013: Nicky James Named Vice President and Global Leader of Cook Medical Aortic Intervention Clinical Division 76
7.1.9 Jul 09, 2013: CryoLife Enhances International Presence with Appointment of Andres Sarmiento as Latin America Sales Manager 76
7.2 Financial Announcements 77
7.2.1 May 01, 2014: Cardica Announces Fiscal 2014 Third Quarter Financial Results 77
7.2.2 May 01, 2014: SurModics Reports Second Quarter Fiscal 2014 Results 78
7.2.3 Apr 24, 2014: Merit Medical Reports Sales Up 15% for the Quarter Ended March 31, 2014 80
7.2.4 Feb 24, 2014: Merit Medical Reports Record Revenues for the Quarter and Year Ended December 31, 2013 81
7.2.5 Feb 20, 2014: CryoLife Fourth Quarter 2013 Revenues Increased 8 Percent to a Record $35.5 Million 83
7.2.6 Feb 18, 2014: Medtronic Reports Third Quarter Earnings 85
7.2.7 Feb 04, 2014: Cardica Announces Fiscal 2014 Second Quarter Financial Results 87
7.2.8 Jan 30, 2014: SurModics Reports First Quarter Fiscal 2014 Results 88
7.2.9 Nov 19, 2013: Medtronic Reports Second Quarter Earnings 89
7.2.10 Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014 91
7.2.11 Nov 05, 2013: SurModics Reports Fourth Quarter and Full Year 2013 Results 91
7.2.12 Nov 04, 2013: Cardica Announces Fiscal 2014 First Quarter Financial Results 93
7.2.13 Oct 29, 2013: CryoLife Third Quarter 2013 Revenues Increase 8 Percent to a Record $36.3 Million 95
7.2.14 Oct 29, 2013: SurModics to Webcast Fourth Quarter and Fiscal Year 2013 Earnings Conference Call on November 5 97
7.2.15 Oct 23, 2013: Merit Medical Announces Results for the Quarter Ended September 30, 2013 97
7.2.16 Oct 21, 2013: Cardica To Announce Fiscal 2014 First Quarter Financial Results On Monday, November 4, 2013 99
7.2.17 Oct 14, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Third Quarter Financial Results 99
7.2.18 Oct 07, 2013: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Third Quarter Ended September 30, 2013 99
7.2.19 Aug 20, 2013: Medtronic Reports First Quarter Earnings 99
7.2.20 Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014 101
7.2.21 Aug 05, 2013: Cardica Announces Fiscal 2013 Fourth Quarter And Full Year Financial Results 101
7.2.22 Jul 31, 2013: SurModics Reports Third Quarter Fiscal 2013 Results 103
7.2.23 Jul 31, 2013: Merit Medical Reports Record Revenues, up Nine Percent, for the Quarter and Six Months Ended June 30, 2013 104
7.2.24 Jul 25, 2013: CryoLife Reports Record Second Quarter Revenues 106
7.2.25 Jul 23, 2013: SurModics to Webcast Third Quarter 2013 Earnings Conference Call on July 31 108
7.2.26 Jul 22, 2013: Cardica to Announce Fiscal 2013 Fourth Quarter and Full Year Financial Results On Monday, August 5, 2013 108
7.2.27 Jul 11, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results 109
7.2.28 Jul 11, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results 109
7.2.29 Jul 08, 2013: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2013 109
7.2.30 May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013 110
7.2.31 May 07, 2013: SurModics Reports Second Quarter Fiscal 2013 Results 111
7.3 Government and Public Interest 113
7.3.1 Jan 06, 2014: Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference 113
7.3.2 Dec 04, 2013: SurModics to Present at Oppenheimer Healthcare Conference 113
7.3.3 Dec 04, 2013: Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference 113
7.3.4 Nov 26, 2013: SurModics to Present at Piper Jaffray Healthcare Conference 113
7.3.5 Nov 26, 2013: Medtronic EVP & President Mike Coyle to Speak at Piper Jaffray Healthcare Conference 114
7.3.6 Nov 26, 2013: Merit Medical to Participate at Piper Jaffray Healthcare Conference 114
7.3.7 Nov 25, 2013: CryoLife to Present at 25th Annual Piper Jaffray Healthcare Conference 114
7.3.8 Nov 12, 2013: Merit Medical to Present at Stephens and Canaccord Genuity Conferences This Week 114
7.3.9 Nov 12, 2013: SurModics to Present at Canaccord Genuity Medical Technology & Diagnostics Conference 115
7.3.10 Sep 11, 2013: Cardica To Present At Craig-Hallum Alpha Select Conference 115
7.3.11 Sep 06, 2013: Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference 115
7.3.12 Sep 03, 2013: Merit Medical to Present at CL King Conference 115
7.3.13 Aug 27, 2013: SurModics to Present at CL King’s Best Ideas Conference 115
7.3.14 Aug 07, 2013: Cardica to Present at Wedbush 2013 Life Sciences Management Access Conference 116
7.3.15 Aug 01, 2013: Merit Medical to Participate at Canaccord Genuity Growth Conference 116
7.3.16 May 21, 2013: SurModics to Present at the Jefferies Global Healthcare Conference 116
7.4 Legal And Regulatory 116
7.4.1 Apr 11, 2014: Federal Court Orders Preliminary Injunction on U.S. Sales of Medtronic's Infringing Transcatheter Valve 116
7.4.2 Mar 12, 2014: Venaxis to Discuss Top-Line Results from Pivotal Study of APPY1 Test 117
7.4.3 Jan 22, 2014: Medtronic Statement on U.S. Supreme Court Ruling in Medtronic, Inc. v. Mirowski Family Ventures 117
7.4.4 Oct 19, 2013: Medtronic Statement on Medical Device Security 118
7.4.5 Aug 01, 2013: Medtronic Notifies More Than 2,700 Patients Of Lost Records 118
7.4.6 Jul 01, 2013: Bronstein, Gewirtz & Grossman, LLC Announces that a Securities Class Action has been Filed Against Medtronic, Inc. 119
7.4.7 May 29, 2013: Edwards Lifesciences Gets FDA Warning Letter Regarding Cardiac Surgery Systems 119
7.5 Other Significant Developments 120
7.5.1 Feb 24, 2014: Cesca Therapeutics and Cook Medical Enter Supply Agreement for a Phase 1b Clinical Trial 120
7.5.2 Feb 19, 2014: CryoLife Announces Quarterly Cash Dividend for the First Quarter 2014 120
7.5.3 Feb 13, 2014: Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2014 120
7.5.4 Jan 28, 2014: Medtronic Relocates Its Regional Headquarters to Dubai 121
7.5.5 Jan 27, 2014: Saint Luke's awarded $3.4 million grant from Boston Scientific for further research into innovative cardiac procedures 122
7.5.6 Dec 16, 2013: Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases 123
7.5.7 Dec 04, 2013: Medtronic Issues $500,000 in Health Access Grants to Support Diabetes Services for the Underserved of Greater Los Angeles 123
7.5.8 Nov 21, 2013: CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2013 125
7.5.9 Sep 03, 2013: SurModics Announces Organizational Changes 125
7.5.10 Aug 22, 2013: Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2014 126
7.5.11 Aug 21, 2013: CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2013 126
7.5.12 Jul 22, 2013: SurModics to Present at the InvestMNt Conference 126
7.5.13 Jul 12, 2013: Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Vascular Closure Devices 126
7.6 Product News 127
7.6.1 Nov 18, 2013: New Study May Impact Practice Guidelines for Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation 127
7.6.2 Nov 18, 2013: LVAD Patients Benefit from Heart Injection with Millions of Powerful Cells 128
7.6.3 Nov 15, 2013: FDA Classifies Medtronic's Worldwide Voluntary Field Action on Guidewires as Class I Recall 129
7.6.4 Nov 14, 2013: Endovascular Aneurysm Training Module Now Supports Vascutek's Anaconda Devices 129
7.7 Research And Development 130
7.7.1 May 30, 2013: Cook Medical Joins With Indiana Life Science Businesses, Academia And Government To Help Launch Bioscience Research Center 130
7.8 Strategy And Business Planning 131
7.8.1 Mar 15, 2014: Merit Medical Opens Office in Bangalore, India 131
7.8.2 Feb 04, 2014: Purdue Research Foundation, Cook Medical partner on $12 million project to support life sciences startup opportunities 131
7.8.3 Nov 14, 2013: Cook Medical Opens New Innovation Centre in Limerick, Ireland 132
7.8.4 Sep 17, 2013: Medtronic Opens New Customer Innovation Centre in Galway, Ireland 133
7.8.5 Sep 02, 2013: Medtronic announces formation of hospital solutions business aimed at driving efficiencies 133
7.8.6 Aug 29, 2013: Medtronic To Set Up Global Center Of Excellence In Singapore For Business Model Innovation 135

8 Appendix 136
8.1 Research Methodology 137
8.1.1 Coverage 137
8.1.2 Secondary Research 137
8.1.3 Primary Research 138
8.1.4 Market Modeling and Forecasting 139
8.1.5 Company Share Analysis 142
8.1.6 Distribution Share Analysis 143
8.2 Expert Panel 143
8.3 GlobalData Consulting 144
8.4 Contact Us 144
8.5 Disclaimer 144

List of Tables


Table 1: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 13
Table 2: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 15
Table 3: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 17
Table 4: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 19
Table 5: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 21
Table 6: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 23
Table 7: Cardiovascular Surgery Market, United States, Volume (Units), Historic, 2005-2012 25
Table 8: Cardiovascular Surgery Market, United States, Volume (Units), Forecast, 2012-2020 27
Table 9: Beating Heart Surgery Systems Market, United States, Volume (Units), Historic, 2005-2012 29
Table 10: Perfusion Disposables Market, United States, Volume (Units), Historic, 2005-2012 31
Table 11: Beating Heart Surgery Systems Market, United States, Volume (Units), Forecast, 2012-2020 33
Table 12: Perfusion Disposables Market, United States, Volume (Units), Forecast, 2012-2020 35
Table 13: Cardiovascular Surgery Market, United States, Average Price ($), Historic, 2005-2012 36
Table 14: Cardiovascular Surgery Market, United States, Average Price ($), Forecast, 2012-2020 37
Table 15: Cardiovascular Surgery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 38
Table 16: Cardiovascular Surgery Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 40
Table 17: Cardiovascular Surgery Market Pipeline Products 43
Table 18: Sorin Acquires California Medical Labs, Maker Of Cardiovascular Cannulae, For US$14 Million 44
Table 19: Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 46
Table 20: Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 48
Table 21: Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 50
Table 22: Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 52
Table 23: Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 54
Table 24: Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 56
Table 25: Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 58
Table 26: Cardica Prices Public Offering Of Preferred Stock For US$16.3 Million 60
Table 27: Cardica Completes Public Offering Of Shares For US$31.8 Million 62
Table 28: Cardica Completes Public Offering Of Shares For US$15 Million 64
Table 29: Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse 65
Table 30: Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 66
Table 31: Minnetronix Enters Into Licensing Agreement With Penn State Research Foundation For Wireless Energy Transmission Technology 67
Table 32: Tenaxis Medical Raises US$1.4 Million In Venture Financing 68
Table 33: Medrobotics Raises US$21.3 Million In Venture Financing 69
Table 34: BioVentrix Raises US$0.5 Million In Venture Financing 70
Table 35: CHF Technologies Raises US$0.8 Million In Venture Financing 71
Table 36: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 139

List of Figures


Figure 1: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 12
Figure 2: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Figure 3: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 16
Figure 4: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 18
Figure 5: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 20
Figure 6: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 22
Figure 7: Cardiovascular Surgery Market, United States, Volume (Units), Historic, 2005-2012 24
Figure 8: Cardiovascular Surgery Market, United States, Volume (Units), Forecast, 2012-2020 26
Figure 9: Beating Heart Surgery Systems Market, United States, Volume (Units), Historic, 2005-2012 28
Figure 10: Perfusion Disposables Market, United States, Volume (Units), Historic, 2005-2012 30
Figure 11: Beating Heart Surgery Systems Market, United States, Volume (Units), Forecast, 2012-2020 32
Figure 12: Perfusion Disposables Market, United States, Volume (Units), Forecast, 2012-2020 34
Figure 13: Cardiovascular Surgery Market, United States, Company Share (%) 2012 39
Figure 14: GlobalData Epidemiology-Based Forecasting Model 141
Figure 15: GlobalData Capital Equipment-Based Forecasting Model 142
Figure 16: Primary Interviews by Participant Type (%) 143

Upcoming Reports:

Antifungal Drugs: Technologies And The Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018
By - Transparency Market Research
Fungal infections occur due to unhygienic, damp, and unclean environment. They are caused by microscopic organisms that can invade the epithelial tissue. Most dermal infections are the tinea group of infections and are commonly observed in people. They affect nails, hair, scalp, and the skin in various areas of the body. Systemic fungal infections are caused by the ingestion or inhalation of spores and cause fungal pneumonia and opportunistic fungus causes diseases such as candidaisis, meningitis, mucormycosis and some others. There is a very broad base of fungal diseases in humans...
Greece: market of woven cotton fabrics
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the woven cotton fabrics market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the woven cotton fabrics market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate...
Automotive Paint Additives Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018
By - Transparency Market Research
Paint additives are formulations which are antifungal, antibacterial, adhesive, flow enhancing, and have odor modifying properties, which paint might otherwise lack. They are generally added in small amounts yet have a significant effect on the paint. The automotive paint additives market can be segmented into rheology modifiers, catalysts, preservatives, driers, and foam control agents surfactants.  The world market of automotive paint coating is growing at a considerable pace. The market is growing due to the restrictions on the use of solvents based paints which are...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...